AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024
Go back to AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024| Amgen Inc (NASDAQ: AMGN) | Delayed: 393.16 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $393.16 | 52 Week High | $176.85 | |||
| Open | $393.16 | 52 Week Low | $133.64 | |||
| Day High | $393.16 | P/E | 59.21 | |||
| Day Low | $393.16 | EPS | $6.64 | |||
| Volume | 1,110 | |||||

